A case of natural killer cell lymphoma presenting with bilateral pleural effusions and hemophagocytic lymphohistocytosis

Pediatric Blood and Cancer

Volumn 52, Issue 5, 2009, Pages 666-669

  Tai, Chun Fu ^a   Chang, Luan Yin ^a   Lin, Dong Tsamn ^a   Lin, Kai Hsin ^a   Jou, Shiann Tarng ^a   Yang, Yung Li ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bilateral pleural effusions; Epstein Barr virus; Hemophagocytic lymphohistocytosis; Natural killer cell lymphoma

Indexed keywords

ASPARAGINASE; CORTICOSTEROID; EPIRUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; PREDNISOLONE; VINCRISTINE; VIRUS DNA;

ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; HEMOPHAGOCYTIC LYMPHOHISTOCYTOSIS; HISTIOCYTOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LYMPHOMA; MALE; NATURAL KILLER CELL LYMPHOMA; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; FATALITY; GENETICS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; NATURAL KILLER CELL; PATHOLOGY; RADIOGRAPHY; VIROLOGY;

ADOLESCENT; DNA, VIRAL; FATAL OUTCOME; HERPESVIRUS 4, HUMAN; HUMANS; KILLER CELLS, NATURAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOMA; MALE; PLEURAL EFFUSION, MALIGNANT; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63649125466     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21943     Document Type: Article

References (20)

1. Kwong YL. Natural killer-cell malignancies: Diagnosis and treatment. Leukemia 2005;19:2186-2194.
2. Henter JI, Arico M, Egeler RM, et al. Hlh-94: A treatment protocol for hemophagocytic lymphohistiocytosis. Hlh study group of the histiocyte society. Med Pediatr Oncol 1997;28:342-347.
3. Liang X, Graham DK. Natural killer cell neoplasms. Cancer 2008; 112:1425-1436.
4. Mizuki M, Ueda S, Tagawa S, et al. Natural killer cell-derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bites and reactivated Epstein-Barr virus infection. Am J Hematol 1998;59:309-315.
5. Laohaburanakit P Hardin KA. Nk/t cell lymphoma of the lung: A case report and review of literature. Thorax 2006;61:267 -270.
6. Lee BH, Kim SY, Kim MY, et al. Ct of nasal-type t/nk cell lymphoma in the lung. J Thorac Imaging 2006;21:37-39.
7. Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immunol 2006;6:410-415.
8. Mori N, Yamashita Y, Tsuzuki T, et al. Lymphomatous features of aggressive nk cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and eb virus infection. Histopathology 2000;37:363-371.
9. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker cd56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501-4513.
10. Siu LL, Chan JKKwong YL. Natural killer cell malignancies: Clinicopathologic and molecular features. Histol Histopathol 2002;17:539-554.
11. Chiang AK, Tao Q, Srivastava G, et al. Nasal nk- and t-cell lymphomas share the same type of epstein-barr virus latency as nasopharyngeal carcinoma and hodgkin's disease. Int J Cancer 1996;68:285-290.
12. Lei KI, Chan LY, Chan WY, et al. Diagnostic and prognostic implications of circulating cell-free epstein-barr virus DNA in natural killer/t-cell lymphoma. Clin Cancer Res 2002;8:29-34.
13. Au WY, Pang A, Choy C, et al. Quantification of circulating epstein-barr virus (ebv) DNA in the diagnosis and monitoring of natural killer cell and ebv-positive lymphomas in immunocompe- tent patients. Blood 2004;104:243-249.
14. Kwong YL, Chan ACLiang RH. Natural killer cell lymphoma/ leukemia: Pathology and treatment. Hematol Oncol 1997;15:71 -79.
15. Seam P, Juweid ME Cheson BD. The role of fdg-pet scans in patients with lymphoma. Blood 2007;110:3507-3516.
16. Li CC, Tien HF, Tang JL, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/t-cell or t-cell lymphoma. Cancer 2004;100:366-375.
17. Yong W, Zheng W, Zhu J, et al. Midline nk/t-cell lymphoma nasal-type: Treatment outcome, the effect of l-asparaginase based regimen, and prognostic factors. Hematol Oncol 2006;24: 28-32.
18. Ando M, Sugimoto K, Kitoh T, et al. Selective apoptosis of natural killer-cell tumours by L-asparaginase. Br J Haematol 2005;130:860-868.
19. Yong W, Zheng W, Zhang Y, et al. L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type t/nk-cell lymphoma. Int J Hematol 2003;78:163-167.
20. Suzuki R, Suzumiya J, Nakamura S, et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006;37:425-431.